Prevalence, severity, and risk factor of breakthrough infection after vaccination with either the Covaxin or the Covishield among healthcare workers: A nationwide cross-sectional study

BACKGROUND AND AIMS: The coronavirus disease-2019 (COVID-19) pandemic has grappled the entire globe since the beginning of 2020. In India, two vaccines were released in January 2021, the Covaxin® and the Covishield™. However, despite vaccination, many breakthrough infections were reported during the...

Descripción completa

Detalles Bibliográficos
Autores principales: Krishna, Bhavya, Gupta, Anju, Meena, Kaushal, Gaba, Astha, Krishna, Shreya, Jyoti, Ruchika, Aeron, Neha, Prashanth, Shruti, Samriti, Ganapathy, Usha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9438823/
https://www.ncbi.nlm.nih.gov/pubmed/36060166
http://dx.doi.org/10.4103/joacp.joacp_436_21

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9438823/
https://www.ncbi.nlm.nih.gov/pubmed/36060166
http://dx.doi.org/10.4103/joacp.joacp_436_21

Ejemplares similares